FC
LH icon

Fairscale Capital’s Labcorp LH Stock Holding History

Fairscale Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Hold
166
– – 0.03% 210
2026
Q1 		$44.3K Hold
166
– – 0.03% 204
2025
Q4 		$41.6K Hold
166
– – 0.03% 203
2025
Q3 		$47.7K Hold
166
– – 0.03% 196
2025
Q2 		$43.2K Hold
166
– – 0.03% 197
2025
Q1 		$38.6K Sell
166
-72
-30% -$17.5K 0.03% 170
2024
Q4 		$54.6K Hold
238
– – 0.05% 156
2024
Q3 		$53.2K Sell
238
-86
-27% -$18.9K 0.05% 157
2024
Q2 		$70.1K Buy
+324
New +$65.9K 0.06% 140

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fairscale Capital's LH Position: Q2 2026 in Review

Fairscale Capital held its Labcorp (LH) position steady in Q2 2026 at 166 shares worth $46.5K. The position accounts for 0.03% of the portfolio, ranked #210.

Fairscale Capital first reported a position in LH in Q2 2024 and has held it in 9 quarters since. The position peaked at $70.1K in Q2 2024. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Fairscale Capital held 166 shares of Labcorp worth $46.5K as of Q2 2026.
  • Fairscale Capital left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.03% of Fairscale Capital's portfolio in Q2 2026, its #210 holding.
  • Fairscale Capital first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • Fairscale Capital's Labcorp position peaked at $70.1K in Q2 2024.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.